Best for 0% commission stocks
Capital at risk. T&Cs apply.
Copy picks from top traders
Commission-free trades
Fractional shares
Get dividend payments
Fractional shares
Get dividend payments
Qualigen Therapeutics Inc (QLGN) is a publicly traded biotechnology business based in the US. Qualigen Therapeutics is listed on the NASDAQ and traded in US dollars. Its current price of $3.76 is 1.3% down on its price a month ago ($3.81).
How to buy shares in Qualigen Therapeutics
- Open a brokerage account. Choose from our top broker picks or compare brokers in depth. To trade US shares you'll need to complete a W8-BEN form – typically part of the sign-up process.
- Fund your account. Add money to your account via bank transfer or debit card.
- Search the platform by ticker symbol. QLGN in this case.
- Choose an order type. Place a market order (or limit order, if you want to try to hold out for a specific price) with your preferred number of shares or investment amount.
- Submit the order. It's that simple.
Our top picks for where to buy Qualigen Therapeutics shares
Best for uninvested cash
Capital at risk. T&Cs apply.
Up to 8.5% interest on uninvested cash
11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools
Commission-free investing
Advanced trading tools
Best for fractional shares
Capital at risk. T&Cs apply.
Earn 4.5% on uninvested funds
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Fractional shares
5,400+ stocks/ETFs
Qualigen Therapeutics stock chart
Use our graph to track the performance of QLGN stock over time.Fees calculator for buying Qualigen Therapeutics shares with popular apps
Find the cheapest way to buy Qualigen Therapeutics shares with our calculator. Bear in mind that both exchange rates and share prices fluctuate in real time, so the costs estimated here are just a guide (refer to platforms themselves for availability and exact pricing).
Quantity of shares
1000
| Platform | Finder Score | Account fee | Min. initial deposit | Trade cost | Link |
|---|---|---|---|---|---|
|
9
Excellent
|
£0 | $100 | £2,836.60 |
Go to siteCapital at risk
|
 |
9.1
Excellent
|
£0 | £0 | £2,843.36 |
Go to siteCapital at risk
|
|
9
Excellent
|
From £0 | £0 | £2,835.20 |
Go to siteCapital at risk
|
 |
8.8
Great
|
£0 | £0 | £2,816.33 |
Go to siteCapital at risk
|
|
9.2
Excellent
|
£0 | £0 | £2,829.57 |
Go to siteCapital at risk
|
 |
8.5
Great
|
£0 (0.45% for funds) | £1 | £2,855.59 |
Go to siteCapital at risk
|
Full comparison of share dealing platforms
These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Qualigen Therapeutics stock?
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
Technical analysis
View Qualigen Therapeutics's price performance, share price volatility, historical data and technicals.
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Historical closes compared with the last close of $3.76
| 1 week (2025-05-15) | -4.57% |
|---|---|
| 1 month (2025-04-22) | -1.31% |
| 3 months (2025-02-22) | 5.98% |
| 6 months (2024-11-22) | -22.17% |
| 1 year (2024-05-22) | -73.74% |
| 2 years (2023-05-22) | -92.17% |
| 3 years (2022-05-22) | -85.86% |
| 5 years (2020-05-22) |
Invest in Qualigen Therapeutics shares
Finder AwardFree Trades
- Over 5,500+ stocks from 20 exchanges
- Free to open an account
- Commission-free trading
Go to site
Capital at risk
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Qualigen Therapeutics under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Qualigen Therapeutics P/E ratio, PEG ratio and EBITDA.
Qualigen Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Qualigen Therapeutics's shares trade at around 0x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of March 2025 (25.37). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Qualigen Therapeutics's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.
- Synlogic (SYBX.US): 4.91
Frequently asked questions
Ready to compare platforms?More resources on Finder
More guides on Finder
-
Best care home stocks 2025
Find out the best care home shares along with the pros and cons of investing in this grey-pound-fuelled sector.
-
Mental health stocks: Popular mental health companies to invest in
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
-
Invest in pharmaceutical stocks
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
-
How to buy Curaleaf Holdings shares
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
-
How to buy Eli Lilly and Company shares
Ever wondered how to buy shares in Eli Lilly and Company? We explain how to invest in Eli Lilly in the UK along with platforms for buying stock.
-
How to buy Aurora Cannabis shares
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
-
How to buy Walgreens Boots Alliance shares
Ever wondered how to buy shares in Walgreens? We explain how and compare a range of providers that can give you access to many brands, including Walgreens.
-
How to buy Medtronic shares
Ever wondered how to buy shares in Medtronic? We explain how and compare a range of providers that can give you access to many brands, including Medtronic.
-
How to buy AstraZeneca shares
Ever wondered how to buy shares in AstraZeneca? We explain how and compare a range of providers that can give you access to many brands, including AstraZeneca.
-
How to buy GSK shares
Learn more about GSK’s recent performance and where you can buy GSK shares. We also run through a helpful checklist for anyone looking to invest.